BIODESIX, INC. Increase (Decrease) in Other Noncurrent Assets
BIODESIX, INC. (BDSX) reported Increase (Decrease) in Other Noncurrent Assets of -$1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- BIODESIX, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.02M, a 5200.00% decline year-over-year.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$19.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$9.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $125.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $121.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$68.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$33.00K, a 100.94% decline from fiscal 2022.
- BIODESIX, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $3.50M.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.04M 10-Q · filed 2026-08-05 | -$1.05M derived: sum of 3 quarters · filed 2026-08-05 | -$923.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$19.00K 10-Q · filed 2026-05-04 | -$28.00K derived: sum of 2 quarters · filed 2026-05-04 | $97.00K derived: sum of 3 quarters · filed 2026-05-04 | $117.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $116.00K derived: sum of 2 quarters · filed 2026-02-26 | $136.00K derived: sum of 3 quarters · filed 2026-08-05 | $121.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $145.00K derived: sum of 2 quarters · filed 2026-08-05 | $130.00K 10-Q · filed 2025-11-03 | $111.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.00K 10-Q · filed 2026-08-05 | -$14.00K derived: sum of 3 quarters · filed 2026-08-05 | -$51.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$15.00K 10-Q · filed 2026-05-04 | -$34.00K derived: sum of 2 quarters · filed 2026-05-04 | -$71.00K derived: sum of 3 quarters · filed 2026-05-04 | -$105.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$56.00K derived: sum of 2 quarters · filed 2026-02-26 | -$90.00K derived: sum of 3 quarters · filed 2026-02-26 | -$68.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$71.00K derived: sum of 2 quarters · filed 2025-11-03 | -$49.00K 10-Q · filed 2025-11-03 | -$108.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$12.00K 10-Q · filed 2025-08-07 | -$71.00K derived: sum of 3 quarters · filed 2025-08-07 | |
| 2024-03-31 | $22.00K 10-Q · filed 2025-05-13 | -$37.00K derived: sum of 2 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$33.00K 10-K · filed 2025-03-03 | ||
| 2023-09-30 | $26.00K 10-Q · filed 2024-11-01 | |||
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-08 | -$131.00K derived: sum of 2 quarters · filed 2024-05-08 | $4.45M derived: sum of 3 quarters · filed 2024-05-08 | $3.98M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $4.44M derived: sum of 2 quarters · filed 2024-03-01 | $3.97M derived: sum of 3 quarters · filed 2024-03-01 | $3.50M 10-K · filed 2024-03-01 |
| 2022-09-30 | $4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.11M derived: sum of 2 quarters · filed 2023-11-07 | $3.65M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$933.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | -$466.00K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$441.00K derived: sum of 2 quarters · filed 2022-11-03 | -$665.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$447.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$224.00K 10-Q · filed 2022-05-11 | |||
| 2020-09-30 | $5.00K 10-Q · filed 2020-12-10 | |||
| 2019-09-30 | -$10.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |